GM Rice Researcher Fights Retraction

Nutrition scientist Guangwen Tang, who was barred from conducting human studies after an investigation found that she did not comply with ethical regulations, goes to court to save her research.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, IRRIIn hopes of preventing the retraction of her 2012 paper in The American Journal of Clinical Nutrition, which led to much controversy regarding whether the researchers used proper consenting practices to enroll the 24 children participants of the study, nutrition scientist Guangwen Tang is suing the American Society for Nutrition (ASN) and her institution, Tufts University, ScienceInsider reported last week (July 17).

The study involved testing the effects of the genetically modified (GM) rice called golden rice that aim to fight vitamin A-deficiency in school-aged Chinese children; the researchers wanted to determine how efficiently β-carotene is converted into the essential vitamin. Soon, accusations flew that the group had not gone through the proper consenting processes. That December, the Chinese Centre for Disease Control (CDC) fired the three China-based authors and offered financial compensation to the parents of the study participants. Tang retired from Tufts University the following September after an internal investigation that the research was not conducted “in full compliance with IRB [institutional review board] policy or federal regulations.”

Now, the ASN wants to withdraw the paper, but Tang argued in a Massachusetts court this month ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies